WINNIPEG, MB / TheNewswire / May 20, 2019 – DELTA 9 CANNABIS INC. (TSXV: NINE) (OTCQX: VRNDF) (“Delta 9” or the “Company”), is pleased to announce that it has received Health Canada approval to place 48 new “Grow Pods” from its Phase II expansion into production. As previously disclosed, Delta 9’s proprietary cannabis production methodology is based around a modular, scalable, and stackable production unit called a grow pod (a “Grow Pod”).

The Company is now working to place 36 flowering Grow Pods and 12 support Grow Pods into production, which will bring the total number of Grow Pods approved by Health Canada and in production to 202. The Company anticipates that this expansion will add an additional 1,150 kilograms per year of dried cannabis flower production, bringing the overall anticipated production capacity for the Company’s facilities to 5,350 kilograms per year.

“This is the next step for Delta 9 in terms of Health Canada expansion approvals for our Phase II expansion. We feel the Grow Pod style of production allows us to scale and license our operations relatively quickly versus our competition,” said John Arbuthnot, CEO of Delta 9, “Additional supply capacity will allow us to pursue additional distribution agreements and secure our place in the Canadian cannabis market.”

The Company continues to install additional Grow Pods within the Phase II expansion areas of its Winnipeg facility. Delta 9’s Phase II plan contemplates expansion of its Winnipeg facilities to up to 608 Grow Pods, producing approximately 16,500 kilograms of cannabis per year.

For more information contact:

Investor & Media Contact:

Ian Chadsey VP Corporate Affairs

Mobile: 204-898-7722


About Delta 9 Cannabis Inc.

Delta 9 Cannabis Inc. is a vertically integrated cannabis company focused on bringing the highest quality cannabis products to market. Delta 9’s wholly-owned subsidiary, Delta 9 Bio-Tech Inc., is a licensed producer of medical and recreational cannabis and operates an 80,000 square foot production facility in Winnipeg, Manitoba, Canada. Delta 9 owns and operates a chain of retail stores under the Delta 9 Cannabis Store brand. Delta 9’s shares trade on the TSX Venture Exchange under the symbol “NINE” and on the OTCQX under the symbol VRNDF. For more information, please visit

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Disclaimer for Forward-Looking Information

Certain statements in this release are forward-looking statements, which reflect the expectations of management regarding the Company’s future business plans and other matters. Forward-looking statements consist of statements that are not purely historical, including any statements regarding beliefs, plans, expectations or intentions regarding the future. Forward looking statements in this news release include statements relating to: (i) increases in Delta 9’s cannabis production capacity; and (ii) Delta 9’s intentions with regards to the distribution of cannabis. Such statements are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the statements, including the Company’s actual financial results being different from its estimates as well as all risk factors set forth in the annual information form of Delta 9 dated April 30, 2019 which has been filed on SEDAR. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are urged to consider these factors carefully in evaluating the forward-looking statements contained in this news release and are cautioned not to place undue reliance on such forward-looking statements, which are qualified in their entirety by these cautionary statements. These forward-looking statements are made as of the date hereof and the Company disclaims any intent or obligation to update publicly any forward-looking statements, whether as a result of new information, future events or results or otherwise, except as required by applicable securities laws.